Share

Usine Nouvelle and Industrie Pharma publish interview with Marc Le Bozec, BSP member and manager at Financière Arbevel






On 21 February 2022, leading business weekly magazine Usine Nouvelle published an interview with manager at Financière Arbevel and member of the Biotech Social Pact, Marc Le Bozec. The interview was initially published in the monthly pharma magazine Industrie Pharma.





Marc Le Bozec introduces the Biotech Social Pact (BSP), its objectives and role, and lays out the measures necessary to promote private financing. According to him, “we must first re-enchant this sector and open it up to other profiles and other industries”.





Read the whole interview on Usine Nouvelle.











		

				

					

		

					

		

							

				

				

					

								

						

					

			

						

				

			
The Biotech Social Pact gathers CEOs and leaders of biotech and life sciences who are committed to working alongside high-level policymakers and health authorities to sustainably grow the biotech ecosystem whilst ensuring timely and widespread access to innovative treatments for patients and health systems across Europe. The Biotech Social Pact does not necessarily reflect the policies or positions of the agencies, organizations, employers, or companies with which the signatories are affiliated. United in upholding common principles and beliefs, our members are diverse assembly of leading organisations that are often not represented in trade associations, including pre- and early commercial companies, venture capital firms and individual industry leaders. The BSP is not a trade association and coexists alongside existing biopharma trade associations. It aims at offering a supporting voice to emerging and rapidly growing global biotech companies and to contribute to awareness of biotech and support the biotech ecosystem at large. Up until 2023, the Biotech Social Pact was managed by Portland, a global Public Affairs company, with the financial support of Alnylam Pharmaceuticals, Amicus and argenx.